This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Göran Källstrand: Innovator in Pharmaceutical Aerosol Formulations
Introduction
Göran Källstrand is a notable inventor based in Bjärred, Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of aerosol technologies. His work focuses on enhancing the delivery of therapeutic agents to patients.
Latest Patents
Göran Källstrand holds a patent for "Aerosol formulations of peptides and proteins." This innovative pharmaceutical aerosol formulation comprises a HFA propellant, a pharmaceutically active polypeptide dispersible in the propellant, and a surfactant that enhances the systemic absorption of the polypeptide in the lower respiratory tract. The invention also includes methods for manufacturing such formulations and their use in treating patients.
Career Highlights
Källstrand is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to advancements in drug delivery systems, particularly in respiratory therapies.
Collaborations
Throughout his career, Källstrand has collaborated with esteemed colleagues, including Kjell Bäckström and Magnus Dahlbäck. These collaborations have fostered innovation and development in the pharmaceutical sector.
Conclusion
Göran Källstrand's contributions to aerosol formulations represent a significant advancement in pharmaceutical technology. His innovative work continues to impact the treatment of patients, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile